Tag Archives: First

HUBER+SUHNER and McLaren Applied launch first 5G edge computing rail antenna

Now enabling 5G applications to run on trains, the HUBER+SUHNER SENCITY® Rail ACTIVE Rooftop antenna is the first-of-its-kind rail antenna that contains an embedded radio and compute module to offer increased data throughput to support 5G services. It is an all-in-one active antenna with a single ethernet cable input for power and data transmission. Travellers… Read More »

Texas’ hospital system confirms its first case of new COVID-19 lambda variant

Loading the player… Just when people were beginning to wrap their heads around the delta variant of COVID-19, this week, Texas’ hospital system has become the first to report a case of the lambda variant. According to ABC News, Monday, Houston Methodist Hospital, which operates eight hospitals in its network, confirmed its first case of the… Read More »

UK’s daily Covid cases rise 49% in a week to above 5,000 for the first time since March 

UK’s daily Covid cases rise 49% in a week to above 5,000 for the first time since March, 18 more deaths are announced and the R-rate soars above 1 – but half of adults are now fully vaccinated Department of Health said there were 5,274 positive tests in past 24 hours, highest daily total since… Read More »

Delta Covid variant first found in India spreads to 62 countries, hot spots form in Asia and Africa, WHO says

A health worker tends to a coronavirus disease (COVID-19) patient supported by a mechanical ventilator and undergoing dialysis at the COVID-19 emergency room of the government hospital National Kidney and Transplant Institute in Quezon City, which has declared overcapacity amid rising numbers of COVID-19 infections in Quezon City, Metro Manila, Philippines, April 26, 2021. Eloisa… Read More »

FDA Approves Rybrevant (amivantamab-vmjw) as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

FDA Approves Rybrevant (amivantamab-vmjw) as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations May 21, 2021 (HORSHAM, P.A.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has granted the accelerated approval of Rybrevant (amivantamab-vmjw) for the… Read More »